InBios International Inc., a leading developer of diagnostics for infectious diseases, announced that the U.S. Department of Health and Human Services (HHS) and the Cohen Foundation have awarded the company $100,000 as a Phase 1 winner in the LymeX Diagnostics Prize competition.
InBios will use the funding to develop an automated, quantified, array-based serum test using machine learning to improve sensitivity in categorizing specimens. The company also will receive an invitation to participate in a second phase.
Read more at: https://www.prweb.com/releases/2022/11/prweb19021200.htm
